cyanopindolol has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atgie, C; Carpene, C; Lafontan, M; Quideau, N; Saulnier-Blache, JS | 1 |
| Ando, M; Ando, Y; Nakamura, M; Obayashi, K; Suga, M; Terazaki, H; Uchino, M; Yamashita, T | 1 |
2 other study(ies) available for cyanopindolol and oxidopamine
| Article | Year |
|---|---|
Hamster adipocyte alpha 2-adrenoceptor changes during fat mass modifications are not directly dependent on adipose tissue norepinephrine content.
Topics: Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Cricetinae; Dioxanes; Energy Intake; Food Deprivation; Hydroxydopamines; Idazoxan; Lipolysis; Male; Mesocricetus; Norepinephrine; Oxidopamine; Pindolol; Quinoxalines; Receptors, Adrenergic, alpha; Sympathectomy, Chemical | 1990 |
Mechanism of anemia associated with autonomic dysfunction in rats.
Topics: Adrenergic beta-Antagonists; Anemia; Animals; Autonomic Nervous System Diseases; Blood Cell Count; Blood Pressure; Epinephrine; Erythrocytes; Erythropoietin; Female; Hematocrit; Hemoglobins; Norepinephrine; Oxidopamine; Pindolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Sympatholytics | 2000 |